PRPH OTC
ProPhase Labs, Inc.
1W: +43.6%
1M: -21.8%
3M: -78.5%
YTD: -95.6%
1Y: -99.7%
3Y: -99.9%
5Y: -99.9%
$0.02
+0.00 (+31.67%)
Weekly Expected Move ±35.8%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$7M
-84.7% ▼
5Y CAGR: -7.3%
Gross Profit
-$150K
-100.9% ▼
Operating Income
-$39M
-78.7% ▼
Net Income
-$53M
-218.0% ▼
EPS (Diluted)
$-26.10
-166.3% ▼
EBITDA
-$32M
-118.1% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $15M | $79M | $123M | $44M | $7M |
| YoY Growth | +47.0% | +444.6% | +55.2% | -63.8% | -84.7% |
| Cost of Revenue | $10M | $46M | $52M | $28M | $7M |
| Gross Profit | $5M | $33M | $71M | $16M | -$150K |
| Gross Margin | 31.7% | 41.5% | 57.6% | 36.6% | -2.2% |
| R&D Expenses | $633K | $520K | $652K | $1M | $594K |
| SG&A Expenses | $8M | $22M | $46M | $35M | $38M |
| Operating Expenses | $9M | $23M | $47M | $38M | $38M |
| Operating Income | -$4M | $10M | $24M | -$22M | -$39M |
| Operating Margin | -27.4% | 12.4% | 19.2% | -48.7% | -570.6% |
| Interest Expense | $295K | $1M | $764K | $1M | $3M |
| Income Before Tax | -$2M | $5M | $23M | -$22M | -$42M |
| Tax Expense | $12K | -$968K | $4M | -$6M | $7M |
| Net Income | -$2M | $6M | $18M | -$17M | -$53M |
| Net Margin | -14.6% | 7.9% | 15.1% | -37.8% | -788.2% |
| EPS (Diluted) | $-0.20 | $0.40 | $1.02 | $-0.98 | $-26.10 |
| EBITDA | -$1M | $11M | $29M | -$15M | -$32M |
| Shares Outstanding | 12M | 18M | 19M | 17M | 2M |